Advantages and disadvantages of recombinant allergens and peptides for specific immunotherapy.
Schou
C
C
ALK-Abelló Group, Hørsholm, Denmark.
D000485:Allergens / Q000276:immunology / Q000627:therapeutic use*; D000818:Animals; D018985:Epitopes, B-Lymphocyte / Q000276:immunology; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D007167:Immunotherapy; D010455:Peptides / Q000276:immunology / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use
D000485:Allergens; D018985:Epitopes, B-Lymphocyte; D018984:Epitopes, T-Lymphocyte; D010455:Peptides; D011994:Recombinant Proteins